Hepatitis C News

Researchers compared estimated national costs of direct-acting antiviral therapy between Germany and Australia to clarify what steps may be necessary to achieve the WHO hepatitis C elimination goals, according to a recently published editorial.

Alcohol use disorders contributed to more than two-thirds of liver-related complications in adults discharged with chronic hepatitis C from French hospitals between 2008 and 2013, according to a recently published study.

Hepatitis C virus infection was associated with an increased risk for cancers other than hepatocellular carcinoma among elderly patients, a registry-based case–control study found.

Long-term Baraclude monotherapy was highly effective in preventing hepatitis B reactivation after liver transplantation in patients with chronic HBV, according to results of a recently published study. The monotherapy also had significantly high rates of hepatitis B surface antigen seroclearance, undetectable HBV DNA and long-term survival.

Community-based treatment with a dedicated primary care program led to sustained virologic response in most homeless and marginally housed patients with hepatitis C enrolled in a recent study.

The WHO prequalified the generic active pharmaceutical ingredient sofosbuvir on Mar. 31, 2017, according to a press release from the organization. This is the first time WHO has prequalified a generic active ingredient for hepatitis C.

Homeless veterans experience a higher prevalence of HIV, hepatitis C virus and hepatitis B virus infection compared with non-homeless veterans, according to a retrospective analysis of VA data.

The FDA has approved Sovaldi and Harvoni as supplemental applications for the treatment of hepatitis C in children aged 12 to 17 years, according to an FDA news release.

Delayed treatment for chronic hepatitis C infection can be detrimental for patients regardless of fibrosis stage, study data showed.

Zepatier treatment for chronic hepatitis C in patients with stage III chronic kidney disease resulted in almost all patients — including patients with HIV coinfection — achieving sustained virologic response and did not worsen renal function, , according to results of a retrospective study.